©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPeroxisome biogenesis disorders, Zellweger spectrum; differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Peroxisome biogenesis disorders containing 14 core candidate genes and altogether 21 curated genes according to the clinical signs

ID
PP0510
Number of genes
21 Accredited laboratory test
Examined sequence length
19,9 kb (Core-/Core-canditate-Genes)
32,5 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
PEX13852NM_000466.3AR
PEX101041NM_153818.2AR
PEX11B780NM_003846.3AR
PEX121080NM_000286.3AR
PEX131212NM_002618.4AR
PEX141134NM_004565.3AR
PEX161011NM_004813.4AR
PEX19900NM_002857.4AR
PEX2918NM_000318.3AR
PEX26918NM_017929.6AR
PEX31122NM_003630.3AR
PEX51920NM_001131025.2AR
PEX62943NM_000287.4AR, AD
PEX7972NM_000288.4AR
ABCD12238NM_000033.4XLR
ACBD51473NM_001042473.4AR
ACOX11869NM_004035.7AR
DNM1L2211NM_012062.5AD, AR
HSD17B42211NM_000414.4AR
PHYH1017NM_006214.4AR
SCP21644NM_002979.5AR

Informations about the disease

Clinical Comment

Peroxisome biogenesis requires the coordinated activity of at least 16 PEX proteins encoded by PEX genes. Partial or generalized defects lead to two disease groups, Zellweger spectrum disorders (ZSD) and rhizomelic chondrodysplasia punctata type 1. Among ZSD, severe, intermediate, and milder forms occur, such as Zellweger syndrome (ZS; cerebro-hepato-renal syndrome), neonatal adrenoleukodystrophy and infantile Refsum disease. Furthermore, variant phenotypes exist for both groups. ZS patients develop hypotonia, feeding problems, hearing/vision loss, and epilepsy as neonates due to leukodystrophy. Affected individuals have characteristic facial features and usually do not survive past the first year of life. Patients with neonatal adrenoleukodystrophy (NALD) or infantile Refsum disease have more variable symptoms and develop the disease late in infancy or early childhood. Here, the disease also typically progresses more slowly. NALD patients survive into childhood, and patients with infantile Refsum disease may reach adulthood. Rare cases show only developmental delays in childhood and hearing loss or vision problems beginning in adulthood without more severe features. Virtually all peroxisome biogenesis disorder are inherited in an autosomal recessive manner, only two of these disorders are autosomal dominant and one is X-linked. Summary studies of diagnostic yield are not available due in part to the immense spectrum of this cerebro-hepato-renal syndrome and variants. Inconspicuous genetic findings do not imply a definite exclusion of the suspected clinical diagnosis.

References: https://www.ncbi.nlm.nih.gov/books/NBK1448/https://www.ncbi.nlm.nih.gov/books/NBK1353/

https://www.ncbi.nlm.nih.gov/books/NBK1270/

https://www.ncbi.nlm.nih.gov/books/NBK1283/

https://www.ncbi.nlm.nih.gov/books/NBK1315/

 

Synonyms
  • Alias: Infantile Refsum disease
  • Alias: Neonatal adrenoleukodystrophy
  • Alias: Peroxisomal biogenesis disturbances
  • Alias: Peroxisome biogenesis disorder spectrum
  • Alias: Zellweger spectrum disorder
  • Allelic: Mitchell syndrome (ACOX1)
  • Allelic: Optic atrophy 5 (DNM1L)
  • Allelic: Perrault syndrome 1 (HSD17B4)
  • Allelic: Rhizomelic chondrodysplasia punctata, type 1 (PEX7)
  • Allelic: Rhizomelic chondrodysplasia punctata, type 5 (PEX5)
  • Adrenoleukodystrophy (ABCD1)
  • Adrenomyeloneuropathy, adult (ABCD1)
  • D-bifunctional protein deficiency (HSD17B4)
  • Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1 (DNM1L)
  • Heimler syndrome 1 [Peroxisome biogenesis disorder 1C] (PEX1)
  • Heimler syndrome 2 [Peroxisome biogenesis disorder 4C] (PEX6)
  • Krabbe disease (GALC)
  • Leukoencephalopathy with dystonia and motor neuropathy (SCP2)
  • Metachromatic leukodystrophy (ARSA)
  • Peroxisomal acyl-CoA oxidase deficiency (ACOX1)
  • Peroxisome biogenesis disorder 10A [Zellweger] (PEX3)
  • Peroxisome biogenesis disorder 10B (PEX3)
  • Peroxisome biogenesis disorder 11A [Zellweger] (PEX13)
  • Peroxisome biogenesis disorder 11B (PEX13)
  • Peroxisome biogenesis disorder 12A [Zellweger] (PEX19)
  • Peroxisome biogenesis disorder 13A [Zellweger] (PEX14)
  • Peroxisome biogenesis disorder 14B (PEX11B)
  • Peroxisome biogenesis disorder 1A [Zellweger] (PEX1)
  • Peroxisome biogenesis disorder 1B [NALD/IRD] (PEX1)
  • Peroxisome biogenesis disorder 2A [Zellweger] (PEX5)
  • Peroxisome biogenesis disorder 2B (PEX5)
  • Peroxisome biogenesis disorder 3A [Zellweger] (PEX12)
  • Peroxisome biogenesis disorder 3B (PEX12)
  • Peroxisome biogenesis disorder 4A [Zellweger] (PEX6)
  • Peroxisome biogenesis disorder 4B (PEX6)
  • Peroxisome biogenesis disorder 5A [Zellweger] (PEX2)
  • Peroxisome biogenesis disorder 5B (PEX2)
  • Peroxisome biogenesis disorder 6A [Zellweger] (PEX10)
  • Peroxisome biogenesis disorder 6B (PEX10)
  • Peroxisome biogenesis disorder 7A [Zellweger] (PEX26)
  • Peroxisome biogenesis disorder 7B (PEX26)
  • Peroxisome biogenesis disorder 8A [Zellweger] (PEX16)
  • Peroxisome biogenesis disorder 8B (PEX16)
  • Peroxisome biogenesis disorder 9B (PEX7)
  • Refsum disease (PHYH)
  • Retinal dystrophy with leukodystrophy (ACBD5)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined